Benjamin Djulbegovic
Overview
Explore the profile of Benjamin Djulbegovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
302
Citations
10207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Djulbegovic B, Hozo I, Koletsi D, Price A, Nunan D, Hemkens L
J Eval Clin Pract
. 2024 Oct;
PMID: 39373266
Rationale, Aims, And Objectives: The previous studies demonstrated that the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, a leading method for evaluating the certainty (quality) of scientific evidence...
2.
Paczesny S, Hozo I, Djulbegovic B
Blood Adv
. 2024 Aug;
8(20):5426-5429.
PMID: 39207866
No abstract available.
3.
Cella C, Djulbegovic B, Hozo I, Lordick F, Bagnardi V, Frassoni S, et al.
Eur J Cancer
. 2024 Aug;
209:114234.
PMID: 39142210
Background: Based on the Khorana score, guidelines recommend anticoagulation for primary prophylaxis (PP) in outpatients with cancer with an intermediate-to-high risk of venous thromboembolism (VTE). ONKOTEV score has been prospectively...
4.
Kepp K, Aavitsland P, Ballin M, Balloux F, Baral S, Bardosh K, et al.
J Clin Epidemiol
. 2024 Jun;
173:111428.
PMID: 38897481
Consensus statements can be very influential in medicine and public health. Some of these statements use systematic evidence synthesis but others fail on this front. Many consensus statements use panels...
5.
6.
Djulbegovic B, Koletsi D, Hozo I, Price A, Martimbianco A, Riera R, et al.
J Clin Epidemiol
. 2024 May;
171():111392.
PMID: 38740313
Objectives: To assess to what extent the overall quality of evidence indicates changes to observe intervention effect estimates when new data become available. Methods: We conducted a meta-epidemiological study. We...
7.
Pai M, Byrne M, Cuker A, Djulbegovic B, George J, Seftel M, et al.
Blood Adv
. 2024 May;
8(13):3553-3554.
PMID: 38695879
No abstract available.
8.
Djulbegovic B, Hozo I, Guyatt G
Blood Adv
. 2024 Apr;
8(13):3596-3606.
PMID: 38625997
Decision analysis can play an essential role in informing practice guidelines. The American Society of Hematology (ASH) thrombophilia guidelines have made a significant step forward in demonstrating how decision modeling...
9.
Djulbegovic B, Boylan A, Kolo S, Scheurer D, Anuskiewicz S, Khaledi F, et al.
Blood Adv
. 2024 Apr;
8(12):3214-3224.
PMID: 38621198
Current hospital venous thromboembolism (VTE) prophylaxis for medical patients is characterized by both underuse and overuse. The American Society of Hematology (ASH) has endorsed the use of risk assessment models...
10.
Cuker A, Kunkle R, Bercovitz R, Byrne M, Djulbegovic B, Haberichter S, et al.
Blood Adv
. 2024 Apr;
8(11):2960-2963.
PMID: 38593461
The American Society of Hematology (ASH) develops a variety of resources that provide guidance to clinicians on the diagnosis and management of blood diseases. These resources include clinical practice guidelines...